When to start dialysis: Theory, evidence and guidelines

Contributions to Nephrology

Volumn 140, Issue , 2003, Pages 176-186

  Tattersall, James ^a  

^a ST JAMES S UNIVERSITY HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 33846941154     PISSN: 03025144     EISSN: None     Source Type: Book Series    
DOI: 10.1159/000071389     Document Type: Article

References (14)

1. Levey AS, Bosch JP, Lewis JB, et al:A more accurate method to estimate glomerular filtration rate from serum creatinine: A new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med 1999;130:461-470.
2. Zucchelli P, Santoro A:How to achieve optimal correction of acidosis in end-stage renal failure patients. Blood Purif 1995;13:375-384.
3. Foley RN, Parfrey PS, Harnett JD, Kent GM, Martin CJ, Murray DC, Barre PE:Clinical and echocardiographic disease in patients starting end-stage renal disease therapy. Kidney Int 1995;47: 186-192.
4. Silberberg JS, Barre PE, Prichard SS, Sniderman AD:Impact of left ventricular hypertrophy on survival in end-stage renal disease. Kidney Int 1989;36:286-290.
5. Tucker B, Fabbian F, Giles M, Thuraisingham RC, Raine AE, Baker LR:Left ventricular hypertrophy and ambulatory blood pressure monitoring in chronic renal failure. Nephrol Dial Transplant 1997;12:724-728.
6. Gerth WC, Remuzzi G, Viberti G, Hannedouche T, Martinez-Castelao A, Shahinfar S, Carides GW, Brenner B:Losartan reduces the burden and cost of ESRD: Public health implications from the RENAAL study for the European Union. Kidney Int 2002;62(suppl 82):68-72.
7. London GM, Pannier B, Guerin AP, Marchais SJ, Safar ME, Cuche JL:Cardiac hypertrophy, aortic compliance, peripheral resistance, and wave reflection in end-stage renal disease. Comparative effects of ACE inhibition and calcium channel blockade. Circulation 1994;90:2786-2796.
8. Cannella G, Paoletti E, Delfino R, Peloso G, Rolla D, Molinari S:Prolonged therapy with ACE inhibitors induces a regression of left ventricular hypertrophy of dialyzed uremic patients independently from hypotensive effects. Am J Kidney Dis 1997;30:659-664.
9. Dyadyk AI, Bagriy AE, Lebed IA, Yarovaya NF, Schukina EV, Taradin GG:ACE inhibitors captopril and enalapril induce regression of left ventricular hypertrophy in hypertensive patients with chronic renal failure. Nephrol Dial Transplant 1997;12:945-951.
10. Tattersall J, Greenwood R, Farrington K:Urea kinetics and when to commence dialysis. Am J Nephrol 1995;15:283-289.
11. Korevaar JC, Jansen MAM, Dekker FW, Jager KJ, Boeschoten EW, Krediet RT, Bossuyt PMM:When to initiate dialysis: Effect of proposed US guidelines on survival. Lancet 2001;358: 1046-1050.
12. Bonomini V, Feletti C, Scolari MP, Stefoni S:Benefits of early initiation of dialysis. Kidney Int Suppl 1985;17:57-59.
13. Adequacy of dialysis and nutrition in continuous peritoneal dialysis:Association with clinical outcomes. Canada-USA (CANUSA) Peritoneal Dialysis Study Group. J Am Soc Nephrol 1996; 7:198-207.
14. Jungers P, Zingraff J, Albouze G, Chauveau P, Page B, Hannedouche T, Man NK:Late referral to maintenance dialysis: Detrimental consequences. Nephrol Dial Transplant 1993;8:1089-1093.